期刊文献+

蛋白激酶D3对前列腺癌细胞中基质金属蛋白酶7的负调控作用 被引量:1

Protein kinase D3 is involved in negative regulation of MMP-7 in prostate cancer cells
下载PDF
导出
摘要 目的探讨蛋白激酶D3(PKD3)对前列腺癌细胞中基质金属蛋白酶7(MMP-7)的调控作用。方法应用佛波脂(PMA,100nmol/L)处理前列腺癌PC3细胞,Westernblotting和实时RT-PCR分别检测PKD3的激酶活性和MMP-7mRNA表达;将siRNA-PKD3瞬时转染PC3细胞以敲低PKD3的表达,同样用实时RT-PCR检测MMP-7mRNA的表达状况;在HEK293细胞中,分别过表达GFP-PKD3、siRNA-PKD3敲低PKD3的表达或先过表达GFP-PKD3再siRNA-PKD3敲低PKD3的表达,以上述同样的方法比较MMP-7mRNA相对表达量的变化。结果在PC-3细胞中,PMA诱导的PKD3的激活可明显降低MMP-7mRNA表达,反之,应用siRNA敲低PKD3的表达则明显提高MMP-7mRNA表达水平(P<0.01);同样,在HEK293细胞中,过表达PKD3可明显降低MMP-7的表达水平,而敲低PKD3可明显提高MMP-7的表达,且敲低PKD3可逆转PKD3过表达诱导的MMP-7下调。结论 PKD3可能通过负调控MMP-7的表达而介导前列腺癌的恶性进程。 Objective To explore the role of protein kinase D3 (PKD3) in the regulation of matrix metalloprteinases 7 (MMP-7) expression in prostate cancer cells. Methods PC-3 cells were either stimulated with 100 nmol/L PMA to activate PKD3 kinase activity, or transiently transfected with PKD3 siRNA, and the relative expression level of MMP-7 mRNA were analyzed by real-time PCR using 2~~method. MMP-7 mRNA levels were also analyzed and quantified in HEK293 cells with over-expression of wild-type PKD3, PKD3 knockdown (using PKD3 siRNA), or over-expression of wild-type PKD3 followed by PKD3 knockdown. Results MMP-7 mRNA expression in PC3 cells was significantly decreased after PMA-induced PKD3 kinase activation. In contrast, PKD3 knockdown by siRNA transfection markedly increased MMP-7 mRNA level (P〈0.01). MMP-7 mRNA level in HEK293 cells was significantly decreased by PKD3 over-expression, whereas obviously increased by PKD3 knockdown. Down-regulation of MMP-7 mRNA level in HEK293 induced by PKD3 over-expression was rescued by PKD3 knockdown. Conclusion PKD3 may contribute to the malignant progression of prostate cancer cells through negative regulation of MMP-7 expression.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2010年第8期1767-1770,共4页 Journal of Southern Medical University
基金 国家自然科学基金(30973014) 教育部留学回国人员科研启动基金(K1010353)
关键词 蛋白激酶D3 基质金属蛋白酶7 前列腺癌 负调控 protein kinase D3 matrix metalloprteinases 7 prostate neoplasm
  • 相关文献

参考文献15

  • 1Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment [J ]. Cell, 2010, 141 (1): 52-67.
  • 2Ii M, Yamamoto H, Adachi Y, et al. Role of matrix metalloproteinasc-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogencsis [J]. Exp Biol Med (Maywood), 2006, 231 (1): 20-7.
  • 3Wang F, Reierstad S, Fishman DA. Matrilysin over-expression in MCF-7 cells enhances cellular invasiveness and pro-gelatinase activation[J]. Cancer Lett, 2006, 236(2): 293-301.
  • 4Noe V, Fingleton B, Jacobs K, et al. Release.of an invasion promoter E-cadherin flagment by matrilysin and stromelysin-1 [J]. J Cell Sci, 2001, 114(1): 111-8.
  • 5Nakamura M, Miyamoto S, Maeda H, et al. Matrix metalloproteinase-7 degrades all insulinlike growth factor binding proteins and facilitates insulin-like growth factor bioavailability [J]. Biochem Biophys Res Commun, 2005, 333(3): 1011-6.
  • 6HuoN, IchikawaY, KamiyamaM, et al. MMP-7 (matrilysin) accelerated growth of human umbilical vein endothelial cells [J]. Cancer Lett, 2002, 177(1): 95-100.
  • 7Zheng HC, Sun JM, Li XH, et al. Role of PTEN and MMP-7 expression in growth, invasion, metastasis and angiogenesis of gastric carcinoma[J]. Pathoi Int, 2003, 53(10): 659-66.
  • 8Wang QJ. PKD at the crossroads of DAG and PKC signaling [ J ]. Trends Pharmacol Sci, 2006, 27(6): 317-23.
  • 9Chen J, Deng F, Singh SV, et al. Protein kinase D3 (PKD3) contributes to prostate cancer cell growth and survival through a PKCepsilon/PKD3 pathway downstream of Akt and ERK 1/2 [J]. Cancer Res, 2008, 68(10): 3844-53.
  • 10Livak K J, Schmittgen TD. Analysis of relative gene expression data using real -time quantitative PCR and the 2 (-Delta Delta C (t)) method[J]. Methods, 2001, 25(4): 402-8.

同被引文献31

  • 1Borensztajn K, Crestani B, Kolb M, et al. Idiopathic pulmonary fibro- sis : from epithelial injury to biomarkers- insights from the bench side [ J]. Respiration,2013,86:441 -452.
  • 2Ohnishi H, Yokoyama A, Kondo K, et al. Comparative study of KL- 6, surfactant protein-A, surfactant protein-D, and monocyte chemoat- tractant protein-1 as serum markers for interstitial lung diseases[ J]. Am J Respir Crit Care Med,2002,165:378 - 381.
  • 3Satoh H, Kurishima K, Ishikawa H, et al. Increased levels of KL-6 and subsequent mortality in patients with interstitial lung diseases [ J]. J Intern Med ,2006,260:429 -434.
  • 4Ishii H, Mukae H, Kadota J, et al. High serum concentrations of sur- factant protein A in usual interstitial pneumonia compared with non- specific interstitial pneumonia[ J]. Thorax,2003,58:52 - 57.
  • 5Nagata N, Kitasato Y, Wakamatsu K, et al. Prognostic value of im- munohistochemical surfactant protein A expression in regenerative/ hyperplastic alveolar epithelial ceils in idiopathic interstitial pneu- monias[ J]. Diagn Patho1,2011,6:25.
  • 6Vuorinen K, Myllarniemi M, Lammi L, et al. Elevated matrilysin levels in bronchoalveolar lavage fluid do not distinguish idiopathic pulmonary fibrosis from other interstitial lung diseases [ J ]. APMIS, 2007,115:969 - 975.
  • 7Rosas IO, Richards TJ, Konishi K, et al. MMP1 and MMP7 as po- tential peripheral blood biomarkers in idiopathic pulmonary fibrosis [ J ]. PLoS Med,2008,5 : e93.
  • 8Richards TJ, Kaminski N, Baribaud F, et al. Peripheral blood pro- teins predict mortality in idiopathic pulmonary fibrosis [ J ]. Am J Respir Crit Care Med,2012,185 ( 1 ) :67 - 76.
  • 9Prasse A, Probst C, Bargagli E, et al. Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis [ J ]. Am J Respir Crit Care Mcd,2009,179:717 - 723.
  • 10Meyer KC, Cardoni A, Xiang ZZ. Vascular endothelial growth factorin bronchoalveolar lavage from normal subjects and patients with diffuse parenchymal lung disease [ J ]. J Lab Clin Med ,2000,135: 332 -338.

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部